Synopsis:
This research aimed at evaluating the effect of proteasome inhibitor MG-132 in mice with inflammatory acute viral myocarditis and found that MG-132 protects mice from coxsackie virus B3 virus-induced acute viral myocarditis through suppressing the expression of inflammatory factors.